# ESBA105 in Patients With Severe Dry Eye

> **NCT01338610** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 334 (actual)

## Conditions studied

- Eyes Dry Chronic

## Interventions

- **BIOLOGICAL:** ESBA105 ophthalmic solution
- **OTHER:** ESBA105 vehicle

## Key facts

- **NCT ID:** NCT01338610
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2013-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338610, "ESBA105 in Patients With Severe Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01338610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*